id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-278325-ykcd7d59	Cheung, Carmen Ka Man	Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective	2020-07-28		.txt	text/plain	7672	379	39	Two meta-analyses showed that a lower platelet count is associated with an increased risk of severe disease and mortality in patients with COVID-19 and may serve as a marker for progression of illness [53, 54] . Experience from previous SARS patients, caused by SARS-CoV-1, suggested that coronavirus could cause thrombocytopenia by direct viral infection of bone marrow haematopoietic stem cells via CD13 or CD66a, formation of auto-antibodies and immune complexes, disseminated intravascular coagulopathy (DIC), and consumption of platelet in lung epithelium [61, 62] . The International Society on Thrombosis and Haemostasis (ISTH) suggested all patients (including non-critically ill) who require hospital admission for COVID-19 infection should receive a prophylactic dose of LMWH unless contraindicated (Table 2 ) [102] . Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19	./cache/cord-278325-ykcd7d59.txt	./txt/cord-278325-ykcd7d59.txt